D

DOD Biotech PCL
SET:DOD

Watchlist Manager
DOD Biotech PCL
SET:DOD
Watchlist
Price: 2.46 THB -1.6% Market Closed
Market Cap: 1.1B THB
Have any thoughts about
DOD Biotech PCL?
Write Note

Intrinsic Value

The intrinsic value of one DOD stock under the Base Case scenario is 4.3 THB. Compared to the current market price of 2.46 THB, DOD Biotech PCL is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DOD Intrinsic Value
4.3 THB
Undervaluation 43%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation Backtest
DOD Biotech PCL

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DOD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DOD?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Consumer products Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about DOD Biotech PCL

Provide an overview of the primary business activities
of DOD Biotech PCL.

What unique competitive advantages
does DOD Biotech PCL hold over its rivals?

What risks and challenges
does DOD Biotech PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for DOD Biotech PCL.

Provide P/S
for DOD Biotech PCL.

Provide P/E
for DOD Biotech PCL.

Provide P/OCF
for DOD Biotech PCL.

Provide P/FCFE
for DOD Biotech PCL.

Provide P/B
for DOD Biotech PCL.

Provide EV/S
for DOD Biotech PCL.

Provide EV/GP
for DOD Biotech PCL.

Provide EV/EBITDA
for DOD Biotech PCL.

Provide EV/EBIT
for DOD Biotech PCL.

Provide EV/OCF
for DOD Biotech PCL.

Provide EV/FCFF
for DOD Biotech PCL.

Provide EV/IC
for DOD Biotech PCL.

Show me price targets
for DOD Biotech PCL made by professional analysts.

What are the Revenue projections
for DOD Biotech PCL?

How accurate were the past Revenue estimates
for DOD Biotech PCL?

What are the Net Income projections
for DOD Biotech PCL?

How accurate were the past Net Income estimates
for DOD Biotech PCL?

What are the EPS projections
for DOD Biotech PCL?

How accurate were the past EPS estimates
for DOD Biotech PCL?

What are the EBIT projections
for DOD Biotech PCL?

How accurate were the past EBIT estimates
for DOD Biotech PCL?

Compare the revenue forecasts
for DOD Biotech PCL with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of DOD Biotech PCL and its key competitors using the latest financial data.

Compare historical revenue growth rates
of DOD Biotech PCL against its competitors.

Analyze the profit margins
(gross, operating, and net) of DOD Biotech PCL compared to its peers.

Compare the P/E ratios
of DOD Biotech PCL against its peers.

Discuss the investment returns and shareholder value creation
comparing DOD Biotech PCL with its peers.

Analyze the financial leverage
of DOD Biotech PCL compared to its main competitors.

Show all profitability ratios
for DOD Biotech PCL.

Provide ROE
for DOD Biotech PCL.

Provide ROA
for DOD Biotech PCL.

Provide ROIC
for DOD Biotech PCL.

Provide ROCE
for DOD Biotech PCL.

Provide Gross Margin
for DOD Biotech PCL.

Provide Operating Margin
for DOD Biotech PCL.

Provide Net Margin
for DOD Biotech PCL.

Provide FCF Margin
for DOD Biotech PCL.

Show all solvency ratios
for DOD Biotech PCL.

Provide D/E Ratio
for DOD Biotech PCL.

Provide D/A Ratio
for DOD Biotech PCL.

Provide Interest Coverage Ratio
for DOD Biotech PCL.

Provide Altman Z-Score Ratio
for DOD Biotech PCL.

Provide Quick Ratio
for DOD Biotech PCL.

Provide Current Ratio
for DOD Biotech PCL.

Provide Cash Ratio
for DOD Biotech PCL.

What is the historical Revenue growth
over the last 5 years for DOD Biotech PCL?

What is the historical Net Income growth
over the last 5 years for DOD Biotech PCL?

What is the current Free Cash Flow
of DOD Biotech PCL?

Discuss the annual earnings per share (EPS)
trend over the past five years for DOD Biotech PCL.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
DOD Biotech PCL

Current Assets 471.9m
Cash & Short-Term Investments 75.7m
Receivables 74.2m
Other Current Assets 321.9m
Non-Current Assets 731.8m
Long-Term Investments 2.6m
PP&E 572.6m
Intangibles 46.9m
Other Non-Current Assets 109.7m
Current Liabilities 242.1m
Accounts Payable 99.5m
Short-Term Debt 87.1m
Other Current Liabilities 55.6m
Non-Current Liabilities 74.6m
Long-Term Debt 51.9m
Other Non-Current Liabilities 22.8m
Efficiency

Earnings Waterfall
DOD Biotech PCL

Revenue
710.3m THB
Cost of Revenue
-472.3m THB
Gross Profit
237.9m THB
Operating Expenses
-371.9m THB
Operating Income
-134m THB
Other Expenses
-17.7m THB
Net Income
-151.6m THB

Free Cash Flow Analysis
DOD Biotech PCL

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DOD Profitability Score
Profitability Due Diligence

DOD Biotech PCL's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

24/100
Profitability
Score

DOD Biotech PCL's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

DOD Solvency Score
Solvency Due Diligence

DOD Biotech PCL's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Positive Net Debt
50/100
Solvency
Score

DOD Biotech PCL's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DOD Price Targets Summary
DOD Biotech PCL

There are no price targets for DOD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DOD?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DOD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

DOD Biotech PCL

Country

Thailand

Industry

Consumer products

Market Cap

1.1B THB

Dividend Yield

0%

Description

DOD Biotech Public Co., Ltd. is engaged in manufacture of food supplements. The company is headquartered in Samut Sakhon, Samut Sakhon. The company went IPO on 2018-06-20. The firm operates in five segments: supplementary business, manufacturing cosmetics, network marketing business, manufacturing extraction, and others. Its products categories include beauty products, which includes skincare products and dietary supplements; health products include health supplements, and own-branded products under brand Dieto, which is a protein food supplement, help maintain shape Helps reduce the accumulation of excess fat nervous system. The company offers tablet products, such as capsules and flower tablets. The firm provides drinking powder, such as Fiber Detox, which is a product with high fiber content, which helps in the digestive system. Its subsidiaries include DOD Healthy Life Co., Ltd., Ultima Life Co., Ltd., HY DOD Co., Ltd., and DOD Sale power Co., Ltd.

Contact

SAMUT SAKHON
Samut Sakhon
No. 111 Moo 2 Tha Chin Sub-district, Mueang Samut Sakhon District
+66034446333
www.dodbiotech.com

IPO

2018-06-20

Employees

399

Officers

See Also

Discover More
What is the Intrinsic Value of one DOD stock?

The intrinsic value of one DOD stock under the Base Case scenario is 4.3 THB.

Is DOD stock undervalued or overvalued?

Compared to the current market price of 2.46 THB, DOD Biotech PCL is Undervalued by 43%.

Back to Top